Goodin Susan
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08901, USA.
Am J Health Syst Pharm. 2007 May 1;64(9 Suppl 5):S15-24. doi: 10.2146/ajhp070034.
The mechanisms of action and drug interactions of oral chemotherapeutic agents are reviewed.
The mechanisms of action, indications, and potential for drug interactions vary for oral chemotherapy. Traditional oral chemotherapy agents cause damage to cancer cells by non-specifically interfering with cellular division. Many of the newer agents have novel targets on cancer cells preferentially, resulting in a different spectrum of toxicity. Since cancer patients are at high risk for drug interactions, usually because of age-related organ dysfunction and the need for concomitant drug therapy for comorbid conditions, understanding these agents and potential for interactions is imperative for all healthcare providers.
Knowledge of the mechanisms and metabolic pathways for the oral chemotherapeutic agents allows the potential to predict possible drug interactions and response while minimizing the risk of adverse outcomes.
综述口服化疗药物的作用机制和药物相互作用。
口服化疗的作用机制、适应证及药物相互作用的可能性各不相同。传统口服化疗药物通过非特异性干扰细胞分裂对癌细胞造成损害。许多新型药物优先作用于癌细胞的新靶点,导致不同的毒性谱。由于癌症患者通常因年龄相关的器官功能障碍以及合并症需要联合药物治疗而存在药物相互作用的高风险,所有医疗保健提供者都必须了解这些药物及其相互作用的可能性。
了解口服化疗药物的作用机制和代谢途径有助于预测可能的药物相互作用和反应,同时将不良后果的风险降至最低。